Advertisement

Home / World / China starts phase 2 of human test for vaccine

China starts phase 2 of human test for vaccine

Trial to determine the shot’s dose and evaluate immune responses in healthy people
Children wearing masks chat outside a restaurant in Beijing
Children wearing masks chat outside a restaurant in Beijing
(AP photo)

Reuters   |   Beijing   |   Published 22.06.20, 02:35 AM

Chinese researchers have started a second phase human trial of a possible coronavirus vaccine, the Institute of Medical Biology at Chinese Academy of Medical Sciences (IMBCAMS) said on Sunday, in efforts to further assess effectiveness and safety.

About a dozen vaccines are in different stages of human tests globally, as the World Health Organisation warns the coronavirus pandemic is accelerating and “the world is in a new and dangerous phase”.

Advertisement

However, none of the vaccine trials have passed large-scale, late-stage phase 3 clinical trials, a necessary step before getting regulatory approval for sale.

IMBCAMS began on Saturday a phase 2 human test for its experimental shot, which is among six possible vaccines Chinese scientists are testing in humans, following an on-going phase-1 study that has recruited about 200 participants since May, the institute said on Sunday in its social media channel.

The phase-2 trial will determine the shot’s dose and continue to evaluate whether the potential vaccine can safely trigger immune responses in healthy people.

IMBCAMS said it expects to use a plant dedicated to producing a coronavirus vaccine this year to prepare for China’s future vaccine supplies.

As early as by the end of 2020, certain groups of people with special needs can use experimental vaccines under urgent circumstances, Gao Fu, director at the Chinese Centre for Disease Control and Prevention, said last month.



Advertisement
Advertisement
Advertisement
 
 
 
Copyright © 2020 The Telegraph. All rights reserved.